Molecular Neuropharmacology Lab

Click on the Expand plus sign sign to list the book chapters and other publications by year. Then click on the link for details of that publication.

2022

Collapse All | Expand All

 

  • Miceli F, Soldovieri MV, Weckhuysen S, Cooper E, Taglialatela M. KCNQ2-related disorders. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews((R)). Seattle (WA): 2022. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20437616. [view publication]

<2020

Collapse All | Expand All

 

  • Miceli F, Soldovieri MV, Joshi N, Weckhuysen S, Cooper E, Taglialatela M. KCNQ2-related disorders. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews(R). Seattle (WA): 2016. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20437616. [view publication]
  • Cooper EC. Potassium channels (including KCNQ) and epilepsy. In: Noebels JL, Avoli M, Rogawski MA, Olsen R, W, Delgado-Escueta AV, editors. Jasper's basic mechanisms of the epilepsies. 4th ed. New York: Oxford University Press; 2012. p. 55-65. Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=22787644. [view publication]
  • Miceli F, Soldovieri MV, Joshi N, Weckhuysen S, Cooper EC, Taglialatela M. KCNQ3-related disorders. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mefford HC, Stephens K, Amemiya A, Ledbetter N, editors. GeneReviews(R). Seattle (WA): 1993. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24851285. [view publication]